Amgen | Beneficio Bruto En Ventas


Gross Profit On Sales Cambio
Alexion Pharmaceuticals ALXN:US $ 1299.7M 33.4M
ALKERMES ALKS:US 221.88M 19.41M
Amgen AMGN:US $ 4718M 70M
Astrazeneca AZN:US 5.22B 90M
Biogen BIIB:US $ 2927M 343.5M
Biomarin Pharmaceutical BMRN:US $ 331.52M 59.18M
Bluebird Bio BLUE:US $ 19.73M 17.65M
Bristol Myers Squibb BMY:US $ 7454M 326M
Eli Lilly And LLY:US $ 4277.4M 367.3M
Exelixis EXEL:US $ 250M 33M
Gilead Sciences GILD:US $ 4079M 500M
GlaxoSmithKline GSK:LN 519.5M 111.4M
Glaxosmithkline GSK:US $ 5928M 733M
Intercept Pharmaceuticals ICPT:US $ 75.37M 3.57M
IONIS PHARMACEUT IONS:US $ 142M 12M
Johnson & Johnson JNJ:US $ 14142M 2363M
Merk MRK:US $ 7738M 1075M
Neurocrine Biosciences NBIX:US $ 300M 65M
Novartis NOVN:VX 8.28B 868M
Novartis NVS:US $ 8970M 685M
Pfizer PFE:US $ 9569M 113M
Ptc Therapeutics PTCT:US $ 69.94M 5.76M
Puma Biotechnology PBYI:US $ 61M 19M
Regeneron Pharmaceuticals REGN:US $ 1676.5M 65.6M
Sarepta Therapeutics SRPT:US $ 124M 23M
Seattle Genetics SGEN:US $ 983.44M 753.68M
Takeda 4502:JP Y 539293M 24479M
Ultragenyx Pharmaceutical RARE:US $ 59.91M 20.09M
Vertex Pharmaceuticals VRTX:US $ 1339.96M 12.64M
YTE INCY:US $ 660.08M 113.49M



Amgen Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jan 2021.